Goldman Sachs Group Inc Icad Inc Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Icad Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 21,533 shares of ICAD stock, worth $79,887. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,533
Previous 21,533
-0.0%
Holding current value
$79,887
Previous $44,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ICAD
# of Institutions
64Shares Held
8.01MCall Options Held
67KPut Options Held
40.2K-
Vanguard Group Inc Valley Forge, PA1.21MShares$4.49 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY919KShares$3.41 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT782KShares$2.9 Million0.21% of portfolio
-
First Eagle Investment Management, LLC725KShares$2.69 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny656KShares$2.43 Million0.0% of portfolio
About ICAD INC
- Ticker ICAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,333,900
- Market Cap $94M
- Description
- iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...